¹⁸F-FDG (Fluorodeoxyglucose F-18) is a radiopharmaceutical used in medical imaging, particularly in positron emission tomography (PET) scans. It is a glucose analog labeled with fluorine-18 (¹⁸F), a radioactive isotope. Since many cells, especially cancer cells, consume glucose at a high rate, 18F-FDG is useful for detecting metabolic activity in tissues.

¹⁸F-DOPA (Fluoro-DOPA) is a radiopharmaceutical used primarily in positron emission tomography (PET) imaging to assess dopaminergic function in the brain and to detect certain tumors. It is a modified form of L-DOPA (levodopa), labeled with the radioactive isotope Fluorine-18 (¹⁸F).

¹⁸F-PSMA is a radiopharmaceutical labeled with Fluorine-18 (¹⁸F) that targets prostate-specific membrane antigen (PSMA), a protein highly expressed in prostate cancer cells. It is used in PET/CT or PET/MRI scans to detect and stage prostate cancer with high accuracy.

¹⁸FMISO (Fluoromisonidazole) is a radioactive imaging agent used in PET (Positron Emission Tomography) scans to identify areas of hypoxia (low oxygen levels) in tissues, particularly within tumors. It is labeled with Fluorine-18 (¹⁸F), a positron-emitting isotope, which allows it to be visualized using PET imaging.

¹⁸FLT (Fluorothymidine) is a radiotracer used in PET imaging to assess cell proliferation, particularly in cancer. It is labeled with Fluorine-18 (¹⁸F) and acts as an analog of thymidine, a key component of DNA synthesis.

¹⁸FAPI (Fibroblast Activation Protein Inhibitor) is a radiotracer used in PET imaging to target fibroblast activation protein (FAP), which is overexpressed in cancer-associated fibroblasts (CAFs). These fibroblasts are a key component of the tumor microenvironment, making FAPI PET a promising tool for detecting various types of cancer and fibrosis-related diseases.

¹⁸F-Choline is a PET imaging radiotracer used primarily for detecting prostate cancer and other tumors with high choline metabolism. It is labeled with Fluorine-18 (¹⁸F) and acts as an analog of choline, a key component of cell membrane synthesis.